Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Chest

• Publication date

  1996-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/CHEST.110.3.595PMID 8797398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparison of the extent and duration of hypokalaemia following three nebulized beta2-adrenoceptor agonists

  2004cited by this paper
• AN ANALYSIS OF THE TIME‐RELATIONS OF ELECTROCARDIOGRAMS.

  1997cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society.

  1995cited by this paper
• Dose-effect relationship of the beta-agonists fenoterol and salbutamol in patients with asthma.

  1994cited by this paper
• Proximate delivery of a large experimental dose from salbutamol MDI induces epithelial airway lesions in intubated rabbits.

  1994cited by this paper
• Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer.

  1993cited by this paper
• A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma.

  1993cited by this paper
• Risks versus benefits of inhaled beta 2-agonists in the management of asthma.

  1992cited by this paper
• Risks Versus Benefits of Inhaled β2-Agonists in the Management of Asthma

  1992cited by this paper
• Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study.

  1991cited by this paper
• Respiratory arrest in near-fatal asthma.

  1991cited by this paper
• The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma.

  1990cited by this paper
• Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.

  1990cited by this paper
• The pulmonary and extrapulmonary effects of inhaled β‐agonists in patients with asthma

  1990cited by this paper
• Fenoterol and serum potassium.

  1989cited by this paper
• Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.

  1989cited by this paper
• Severe acute asthma in a pediatric intensive care unit: six years' experience.

  1989cited by this paper
• Effect of fenoterol on plasma potassium and cardiac ectopic activity.

  1989cited by this paper
• Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction.

  1988cited by this paper
• Decrease of plasma potassium due to inhalation of beta‐2‐agonists: absence of an additional effect of intravenous theophylline

  1988cited by this paper
• Tolerance to the Unwanted Effects of Intravenous Terbutaline after Chronic Oral Dosing

  1985cited by this paper
• Hypokalaemia induced by inhalation of fenoterol.

  1985cited by this paper
• [Cardiac tolerance of a beta-2-sympathomimetic spray: fenoterol. Apropos of 37 patients followed using a Holter monitor during a brief treatment protocol].

  1985cited by this paper
• Effect of bronchodilator therapy administered by canister versus jet nebulizer.

  1984cited by this paper
• Extrapulmonary effects of terbutaline during prolonged administration

  1982cited by this paper
• Triplet pregnancy after pulsatile administration of gonadotropin releasing hormone.

  1982cited by this paper
• Self-poisoning with oral salbutamol.

  1981cited by this paper
• Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma.

  1980cited by this paper
• Letter: Obstetric delivery today.

  1976cited by this paper
• Letter: Medical audit.

  1975cited by this paper

• Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.

  2023cites this paper
• 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task

  2023cites this paper
• 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task

  2023cites this paper
• Duplicate Prescription Rates of Long-Acting Bronchodilator Inhalers

  2022cites this paper
• Recent Advances in β2-Agonists for Treatment of Chronic Respiratory Diseases and Heart Failure.

  2020cites this paper
• Bronchodilator test in extreme old age: Adverse effects of short-acting beta-2 adrenergic agonists with clinical repercussion and bronchodilator response.

  2019cites this paper
• Cardiac telemetry 2016: An overview of guidelines and clinical practice

  2016cites this paper
• Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists.

  2016cites this paper
• Interaction between asthma and anxiety : a systematic review of cognitive-behavioural therapies and a qualitative exploration of young people's experiences

  2015cites this paper
• The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis

  2015cites this paper
• Aerosol Therapy in Patients Receiving Noninvasive Positive Pressure Ventilation

  2012cites this paper
• The rise and fall of β-agonists in the treatment of ARDS

  2012cites this paper
• Inhaled β2-Adrenoceptor Agonists

  2012cites this paper
• Comparison of levalbuterol and racemic albuterol based on cardiac adverse effects in children.

  2011cites this paper
• Magnesium , Potassium , and Calcium as Cardiovascular Disease Therapies

  2011cites this paper
• 気管支喘息治療(β2刺激薬吸入)を契機とした多枝冠攣縮によりショックをきたした急性側壁心筋梗塞の1例

  2010cites this paper
• GDAŃSKI UNIWERSYTET MEDYCZNY

  2009cites this paper
• Intensive Care Unit Management of Status Asthmaticus

  2009cites this paper
• 2009 Lifelong Learning And Self-Assessment Study Guide

  2009cites this paper
• Use of β blockers in patients with COPD

  2008cites this paper
• Potential Adverse Effects of Bronchodilators in the Treatment of Airways Obstruction in Older People

  2008cites this paper
• Use of beta2 agonists and risk of acute myocardial infarction in patients with hypertension.

  2008cites this paper
• Overdiagnosis in lung cancer: different perspectives, definitions, implications

  2008cites this paper
• Chapitre 30 – Aérosolthérapie chez le patient en ventilation mécanique

  2008cites this paper
• When do patients need admission to a telemetry bed?

  2007cites this paper
• Chapitre 26 – Aérosolthérapie chez le patient en ventilation mécanique

  2007cites this paper
• The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.

  2007cites this paper
• Bronchodilator Therapy in Mechanically Ventilated Patients: Patient Selection and Clinical Outcomes

  2007cites this paper
• Fenoterol: Pharmacology and Clinical Use

  2006cites this paper
• RS4 AN EVALUATION OF THE ASSOCIATION BETWEEN HEALTH CARE UTILIZATION AND USE OF SALMETEROL AMONG SUBJECTS WITH ASTHMA

  2006cites this paper
• Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone.

  2006cites this paper
• Safety and Efficacy of a New Albuterol Hydrofluoroalkane Formulation for Treating Asthma Symptoms in Children Two to Less Than Four Years of Age

  2006cites this paper
• Cardiac implications for the use of β2‐adrenoceptor agonists for the management of muscle wasting

  2006cites this paper
• Cardiovascular Effects of -Agonists in Patients With Asthma and COPD*

  2006cites this paper
• Effect of short-acting inhaler beta2-agonists on serum cardiac troponin in wheezy infant.

  2005cites this paper
• Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

  2005cites this paper
• Overcoming Gaps in the Management of Asthma in Older Patients

  2005cites this paper
• Inhalation Therapy With Metered-Dose Inhalers and Dry Powder Inhalers in Mechanically Ventilated Patients

  2005cites this paper
• Dexamethasone treatment causes resistance to insulin-stimulated cellular potassium uptake in the rat.

  2004cites this paper
• Myocardial Injury During Standard Treatment of an Adult with Status Asthmaticus

  2004cites this paper
• Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.

  2004cites this paper
• Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.

  2004cites this paper
• [Effect of high doses of broncholytics on the state of cardiovascular system during treatment of sever exacerbation of bronchial asthma].

  2004cites this paper
• Severe exacerbations of asthma.

  2004cites this paper
• Cardiovascular Safety of β2-Adrenoceptor Agonist Use in Patients with Obstructive Airway Disease

  2004cites this paper
• Stabil Astımlı Hastalarda Serum Elektrolit Seviyesi ve EKG Bulgularının Tedavi ile İlişkisi

  2003cites this paper
• Antiobstruktive antiinflammatorische Therapie: ohne Probleme in der Pneumologie, problematisch in der Kardiologie?

  2002cites this paper
• [Controversies in the pharmacological management of acute asthma in children].

  2002cites this paper
• Beta-agonist intrinsic efficacy: measurement and clinical significance.

  2002cites this paper
• Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight.

  2002cites this paper
• [Pharmacodynamics of inhalation broncholytic agents introduced in a single dose by nebulizer in patients with severe exacerbation of bronchial asthma].

  2002cites this paper
• [Anti-obstructive anti-inflammatory therapy: no problems in pneumology, problematic in cardiology?].

  2002cites this paper
• [Continuous fenoterol inhalation by children with severe acute asthma: immediate clinical effects].

  2002cites this paper
• Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction.

  2002cites this paper
• β-agonist intrinsic efficacy: Measurement and clinical significance

  2002cites this paper
• Controvérsias no manejo farmacológico da asma aguda infantil

  2002cites this paper
• Inhibition by fenoterol of human eosinophil functions including β2‐adrenoceptor‐independent actions

  2002cites this paper
• Fenoterol inhibits superoxide anion generation by human polymorphonuclear leukocytes via beta-adrenoceptor-dependent and -independent mechanisms.

  2002cites this paper
• Pharmacologic treatment of the adult hospitalized asthma patient

  2001cites this paper
• Tratamiento de la crisis asmática con salbutamol intravenoso y en nebulización continua en emergencia

  2001cites this paper
• Is There a Need for Another Inhalative β2-Agonist besides Formoterol in Patients with Asthma?

  2001cites this paper
• Revisiting interactions between hypoxaemia and beta2 agonists in asthma.

  2001cites this paper
• THE FATALITY-PRONE ASTHMATIC

  2001cites this paper
• The Risk of Myocardial Infarction Associated with Inhaled β -Adrenoceptor Agonists

  2000cites this paper
• The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists.

  2000cites this paper
• Involvement of Beta-2 Agonist Inhalation and Hypoxemia in Cardiac Arrest

  2000cites this paper
• [The role of beta2-agonists in treatment of severe acute asthma].

  2000cites this paper
• Reducing Adverse Effects of Inhaled Fenoterol through Optimization of the Aerosol Formulation

  1999cites this paper
• Smoking accelerates absorption of inhaled neutrophil elastase inhibitor FK706

  1999cites this paper
• [The treatment of asthmatic crisis].

  1999cites this paper
• Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?

  1999cites this paper
• Asthma mortality: summary of a round-table discussion, New York, January 1997.

  1999cites this paper
• β agonists: What is the evidence that their use increases the risk of asthma morbidity and mortality?

  1999cites this paper
• [The importance of bronchial hyperreactivity in anesthesiology].

  1998cites this paper
• ANESTHESIA FOR THE RESPIRATORY CRIPPLE

  1998cites this paper
• The Current Laboratory Determination of "Respirable Mass" Is Not Clinically Relevant

  1998cites this paper
• Drugs acting on the respiratory tract

  1998cites this paper
• Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler.

  1998cites this paper
• Fenoterol and asthma mortality.

  1998cites this paper
• Cardiovascular effects after inhalation of large doses of albuterol dry powder in rats, monkeys, and dogs: a species comparison.

  1997cites this paper
• Inhaled bronchodilator therapy in mechanically ventilated patients.

  1997cites this paper
• Asthma in pregnancy.

  1997cites this paper
• Treatment of acute asthma.

  1997cites this paper
• Flawed paradigms drive aerosol device selection.

  1997cites this paper
• Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder.

  1997cites this paper
• Metered-dose inhaler accessory devices in acute asthma: efficacy and comparison with nebulizers: a literature review.

  1997cites this paper
• Partial β2-agonists and their impartial assessment

  1996cites this paper
• Partial beta 2-agonists and their impartial assessment.

  1996cites this paper
• Drugs affecting autonomic functions or the extrapyramidal system

  1995cites this paper
• Overdiagnosis in lung cancer: different

  year unknowncites this paper
• cochrane database of systematic

  year unknowncites this paper